The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
Ero Copper Corp.
ERO · the NYSE · USD · Market cap $3.3B
Ero Copper Corp.
PASS · Titan Ethical · score 70.0Price as of 3 Nov 2026Daily close, not a live quote
Screened 2026-11-03 · the tape above runs as of 16:51 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price30.44 USD at the 3 Nov 2026 close
- Fair valueUnder review: our model's value is 1.39x the price, above our 1.35x limit.
- Our regime readMarkdown, as of 3 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.54)
- Last reviewed3 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-03).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.54, read 2026-11-03
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Ero Copper Corp. holds its Markdown at $30.44. The statistical read favours the sellers, held for 16 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 16 days |
| Price at the screen | $30.44 |
| Valuation | 10.84 trailing · 6.49 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.63 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 32.87% | Below 33% | Interest-bearing debt is just 32.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 7.61% | Below 49% | Money owed to the company is 7.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.68% | Below 5% | Only 0.7% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Ero Copper clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ERO's ethical verdict changes
Today ERO passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 1.39x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 3 covering, consensus Buy. The average target sits +42% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCopper miner shows strong numbers but cycle looms
Picture a Brazilian copper pit where one strong price spike fills the coffers fast. Ero Copper is riding exactly that wave, with revenue up 110 percent, a 32 percent profit margin and 32 percent return on equity. The forward multiple sits at just 5.1 times, and the shares trade 35 percent below our fair value mark. Yet the opportunity rating stays at none.
The business passes our ethical screen without issue and three analysts see further upside. Still the low multiple reflects peak cycle earnings rather than a lasting bargain. Copper prices swing hard, and what looks cheap on today's numbers can quickly turn expensive when demand cools. Unknown competitive edge adds another layer of uncertainty.
Currency moves in Brazil, volatile metal markets and the usual capital intensity of mining keep risk elevated. Low multiples in cyclical sectors often signal the top of the earnings cycle, not a margin of safety. Analysis, not advice.
| Forward P/E | 6.5xcheap for a company growing this fast |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 2.95 |
| EPS, forward | 4.93 |
| Revenue growth | +73.9%growing very fast |
| Profit margin | 29.8%healthy profit margins |
| Return on equity | 30.8%an exceptional return on shareholder capital |
| FCF yield | 1.41% |
| Debt to equity | 0.47minimal debt: a conservative balance sheet |
| Current ratio | 1.37adequate liquidity, worth monitoring |
| Beta | 1.63much more volatile than the market |
| 52-week range | 19.10 - 40.83 |
| Market cap | $3.3B |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeERO trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 12% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35. Since the last review it its composite score rose.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 11.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 62.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (3 analysts) rates it buy, with a mean price target of $35.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Ero Copper (TSX:ERO) Stock Looks Like A Bargain On Its 134% Run Yahoo Finance · 9d ago
- Ero Copper's 2027 Outlook: Leverage Down From 2.6x to 0.8x With a 24-Year Growth Project Waiting in the Wings Yahoo Finance · 10d ago
- 3 Sectors Where Volatility Is Creating Entry Points, Not Exit Signals Yahoo Finance · 29d ago
- Olive Resource Capital Provides Update on Investments for September 2026 Yahoo Finance · 29d ago
- Is Ero Copper (TSX:ERO) Fully Valued As Strong Production And Copper Demand Lift Sentiment? Yahoo Finance · 30d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-24 | Maria Elvira Salazar | Republican | sell | 1K–15K |
| 2026-09-04 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-19 | Kevin Hern | Republican | sell | 15K–50K |
| 2026-08-19 | Kevin Hern | Republican | sell | 15K–50K |
| 2026-08-19 | Kevin Hern | Republican | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $28.97 | -10.5% | · | $895 | -10.5% |
| 2 months | $31.15 | -16.8% | · | $832 | -16.8% |
| 3 months | $27.31 | -5.1% | · | $949 | -5.1% |
| 6 months | $25.95 | -0.1% | · | $999 | -0.1% |
| 1 year | $15.66 | +65.5% | · | $1,655 | +65.5% |
| 2 years | $20.68 | +25.3% | · | $1,253 | +25.3% |
| 3 years | $18.18 | +42.6% | · | $1,426 | +42.6% |
| 5 years | $23.51 | +10.3% | · | $1,103 | +10.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ERO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.